Targeting retinoic acid-related orphan receptor γ(RORγ)with inverse agonists presents a promising therapeutic strategy fortreating autoimmune diseases, including psoriasis, rheumatoid arthritis,and multiple sclerosis. This evidence concerns the gene RORC and rheumatoid arthritis.